Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Santo Raffaele Mercuri1, Luigi Naldi21Unità di Dermatologia, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Università Vita-Salute, Milano, Italy; 2Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Unità di Dermatologia,...
Enregistré dans:
Auteurs principaux: | Santo Raffaele Mercuri, Luigi Naldi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5c6f57a6657543289370aadc5dfe79ac |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ustekinumab in the therapy of chronic plaque psoriasis
par: Jenna L O’Neill, et autres
Publié: (2009) -
Infliximab for the treatment of plaque psoriasis
par: Jennifer S Gall, et autres
Publié: (2008) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
par: Matsumoto S, et autres
Publié: (2018) -
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
par: Nicolazzo D, et autres
Publié: (2014) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
par: Hampton P, et autres
Publié: (2021)